Investor Relations

SEC Filings

Document Details

Form
Filing Date
Mar 22, 2023
Document Date
Mar 20, 2023
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.